CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma: ErratumApplied Immunohistochemistry & Molecular Morphology: October 2009 - Volume 17 - Issue 5 - p 464 doi: 10.1097/PAI.0b013e3181b8c211 Errata In the article that appeared on page 196 of the May issue of the journal, reference 42 was incorrect. The correct information for reference 42 is the following:Tot T. Identifying colorectal metases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7– phenotype. Med Sci Monit. 2004;10:BR139–143. This error has been noted in the online version of the article, which is available at www.amjdermatopathology.com. Back to Top | Article Outline REFERENCE1. Saad RS, Silverman JF, Khalifa MA, et al C. CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma. Appl Immunohistochem Mol Morphol. 2009;17:196–201. View Full Text | PubMed | CrossRef © 2009 Lippincott Williams & Wilkins, Inc.